<DOC>
	<DOCNO>NCT02978456</DOCNO>
	<brief_summary>The purpose study compare clinical outcome quantitative coronary angiography -guided Intravascular ultrasound -guided strategy patient significant coronary artery disease undergoing Drug elute stent implantation .</brief_summary>
	<brief_title>Quantitative Coronary Angiography Versus Intravascular Ultrasound GUIDancE Drug-Eluting Stent Implantation</brief_title>
	<detailed_description />
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Coronary Stenosis</mesh_term>
	<criteria>Men woman least 18years age Typical chest pain objective evidence myocardial ischemia suitable elective PCI Significant coronary artery lesion suitable DES ( drugeluting stent ) implantation The patient guardian agree study protocol schedule clinical followup , provide informed , write consent , approve appropriate Institutional Review Board/Ethical Committee respective clinical site . Angiographic exclusion criterion : following 1 . Bypass graft lesion 2 . Impaired delivery IVUS expect : Extreme angulation ( ≥90° ) proximal within target lesion . Excessive tortuosity ( ≥ two 45° angle ) proximal within target lesion . Heavy calcification proximal within target lesion . Previous percutaneous coronary intervention within 6 month index procedure Previous BVS ( bioresorbable vascular scaffold ) implantation Left ventricular ejection fraction ( LVEF ) &lt; 30 % Hypersensitivity contraindication device material degradants cobalt , chromium , nickel , platinum , tungsten , acrylic fluoro polymer adequately premedicated . Persistent thrombocytopenia ( platelet count &lt; 100,000/µl ) Any history hemorrhagic stroke intracranial hemorrhage , Transient ischemic attack ischemic stroke within past 6 month A know intolerance study drug ( aspirin , clopidogrel ticagrelor ) Patients require longterm oral anticoagulant cilostazol Any surgery require general anesthesia discontinuation aspirin and/or ADP antagonist plan within 12 month procedure . A diagnosis cancer ( superficial squamous basal cell skin cancer ) past 3 year current treatment active cancer . Any clinically significant abnormality identify screen visit , physical examination , laboratory test , electrocardiogram , judgment Investigator , would preclude safe completion study . Hepatic disease biliary tract obstruction , significant hepatic enzyme elevation ( ALT AST &gt; 3 time upper limit normal ) . Life expectancy &lt; 1 year noncardiac cardiac cause Unwillingness inability comply procedure describe protocol . Patient 's pregnant breastfeeding childbearing potential .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>IVUS guide PCI</keyword>
	<keyword>QCA guide PCI</keyword>
</DOC>